<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04914299</url>
  </required_header>
  <id_info>
    <org_study_id>2021P001387</org_study_id>
    <nct_id>NCT04914299</nct_id>
  </id_info>
  <brief_title>Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders</brief_title>
  <official_title>Positive Intelligence - Prospective Study Evaluating a Novel Mobile App Based Preventive Behavioral Intervention for Perinatal Mood Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Positive Intelligence Inc.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to investigate whether a novel mobile App-based behavioral&#xD;
      intervention in pregnant women can: (1) prevent and/or decrease the incidence of perinatal&#xD;
      mood disorders (2) decrease the severity and/or duration of perinatal mood disorders in&#xD;
      affected participants (3) increase access of pregnant women to behavioral intervention and&#xD;
      support tools (4) increase the satisfaction of pregnant women with their prenatal care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Perinatal depression is an episode of major or minor depression that occurs during pregnancy&#xD;
      or in the 12 months after birth; it affects about 10% of new mothers. Postpartum depression&#xD;
      accounts for 12.5% of psychologically related hospitalizations among women.&#xD;
&#xD;
      In 2019, the United States Preventive Services Task Force (USPSTF) recommended screening&#xD;
      pregnant women to identify those at risk for perinatal depression and refer them for&#xD;
      counseling. The USPSTF recommendation is based on growing literature indicating that&#xD;
      counseling women at risk for perinatal depression reduce the risk of having an episode of&#xD;
      major depression by 40%.&#xD;
&#xD;
      Supporting that, multiple studies have shown that cognitive-behavioral intervention and&#xD;
      mental health care adjuvant therapy can effectively improve the condition of patients with&#xD;
      postpartum depression. Finally, access to care has also been shown to be an important factor&#xD;
      in determining the success of any intervention. Women across high and low-risk groups often&#xD;
      have barriers to treatment due to stigma, shame, and fear to disclose symptoms to health&#xD;
      providers&#xD;
&#xD;
      In this research, the investigators aim to investigate whether a novel mobile App-based&#xD;
      behavioral intervention can meaningfully increase access and demonstrate a beneficial effect&#xD;
      in preventing anxiety and depression in the postpartum period. Furthermore and adding to the&#xD;
      existing literature in post-partum depression, this study aims to investigate the role of&#xD;
      &quot;positive intelligence&quot;, an integrative positive cognitive behavioral therapy, as a tool in&#xD;
      the prevention and treatment of perinatal mood disorders.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two groups: One receives a novel mobile-App based intervention and the other groups receives standard of care (psychoeducation about postpartum depression, referral and monitoring).</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postpartum Depression Symptoms</measure>
    <time_frame>3rd trimester pregnancy till 6 months postpartum</time_frame>
    <description>Postpartum Depression Symptoms measured by Edinburgh Postnatal Depression Scale postpartum. Scale 1-30,with 0 indicating no symptoms, and 30 indicating the highest severity of symptoms.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Completion of App-based intervention program</measure>
    <time_frame>6 weeks postpartum</time_frame>
    <description>Self reported completion of App based 6 weeks training program.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>6 weeks postpartum to 6 months postpartum</time_frame>
    <description>Patient satisfaction measured by Client Satisfaction Questionnaire scale. scale 8-32, with higher scores indicate greater satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Generalized Anxiety Symptoms</measure>
    <time_frame>3rd trimester pregnancy till 6 months postpartum</time_frame>
    <description>Anxiety Symptoms measured by Generalized Anxiety Scale. scale 0-21, with with 0 indicating no symptoms, and 21 indicating the highest severity of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient depression symptoms and severity</measure>
    <time_frame>3rd trimester pregnancy till 6 months postpartum</time_frame>
    <description>Depression Symptoms measured by Patient Health Questionnaire scale. Scale 0-27, with 0 indicating no symptoms, and 27 indicating the highest severity of symptoms.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Perinatal Depression</condition>
  <condition>Perinatal Anxiety</condition>
  <arm_group>
    <arm_group_label>A novel mobile-App based intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An App-based &quot;positive intelligence&quot; intervention consisting of 6 weeks of weekly videos and support group sessions, and 6 weeks of daily App-guided practices.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard prenatal care and follow up</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>App-based &quot;positive intelligence&quot; intervention</intervention_name>
    <description>A 6 weeks App-guided and support-group based &quot;positive intelligence&quot; cognitive behavioral intervention in addition to standard prenatal and postnatal care</description>
    <arm_group_label>A novel mobile-App based intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Standard prenatal and postnatal care(Providing psychoeducation and referral to psychotherapy or pharmacotherapy based on participant's symptoms).</description>
    <arm_group_label>A novel mobile-App based intervention</arm_group_label>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to read and speak English&#xD;
&#xD;
          -  Have a low-risk singleton pregnancy with more than 24 weeks of gestation&#xD;
&#xD;
          -  Have smartphone with internet access&#xD;
&#xD;
          -  Failure to meet criteria for a diagnosis of MDD in the last two months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Physical or mental disorders which would interfere with their ability to participate&#xD;
             in the study&#xD;
&#xD;
          -  High-risk pregnancy&#xD;
&#xD;
          -  Give birth to a newborn at still-birth or a newborn with congenital anomalies and/or&#xD;
             Medical complications that require special care in hospital&#xD;
&#xD;
          -  Infant has a birth weight lower than 2,500 grams&#xD;
&#xD;
          -  Infant has a 5-minute Apgar score lower than 7&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shay Erisson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mass General Brigham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shay Erisson, MD</last_name>
    <phone>6173322345</phone>
    <email>serisson@partners.org</email>
  </overall_contact>
  <reference>
    <citation>The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression. Obstet Gynecol. 2015 May;125(5):1268-1271. doi: 10.1097/01.AOG.0000465192.34779.dc.</citation>
    <PMID>25932866</PMID>
  </reference>
  <reference>
    <citation>ACOG Committee Opinion No. 757: Screening for Perinatal Depression. Obstet Gynecol. 2018 Nov;132(5):e208-e212. doi: 10.1097/AOG.0000000000002927.</citation>
    <PMID>30629567</PMID>
  </reference>
  <reference>
    <citation>ACOG Committee Opinion No. 736: Optimizing Postpartum Care. Obstet Gynecol. 2018 May;131(5):e140-e150. doi: 10.1097/AOG.0000000000002633.</citation>
    <PMID>29683911</PMID>
  </reference>
  <reference>
    <citation>Morrell CJ, Sutcliffe P, Booth A, Stevens J, Scope A, Stevenson M, Harvey R, Bessey A, Cantrell A, Dennis CL, Ren S, Ragonesi M, Barkham M, Churchill D, Henshaw C, Newstead J, Slade P, Spiby H, Stewart-Brown S. A systematic review, evidence synthesis and meta-analysis of quantitative and qualitative studies evaluating the clinical effectiveness, the cost-effectiveness, safety and acceptability of interventions to prevent postnatal depression. Health Technol Assess. 2016 May;20(37):1-414. doi: 10.3310/hta20370. Review.</citation>
    <PMID>27184772</PMID>
  </reference>
  <reference>
    <citation>US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Grossman DC, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Interventions to Prevent Perinatal Depression: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 Feb 12;321(6):580-587. doi: 10.1001/jama.2019.0007.</citation>
    <PMID>30747971</PMID>
  </reference>
  <reference>
    <citation>Zlotnick C, Johnson SL, Miller IW, Pearlstein T, Howard M. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiatry. 2001 Apr;158(4):638-40.</citation>
    <PMID>11282702</PMID>
  </reference>
  <reference>
    <citation>Zlotnick C, Miller IW, Pearlstein T, Howard M, Sweeney P. A preventive intervention for pregnant women on public assistance at risk for postpartum depression. Am J Psychiatry. 2006 Aug;163(8):1443-5.</citation>
    <PMID>16877662</PMID>
  </reference>
  <reference>
    <citation>McFarlane E, Burrell L, Duggan A, Tandon D. Outcomes of a Randomized Trial of a Cognitive Behavioral Enhancement to Address Maternal Distress in Home Visited Mothers. Matern Child Health J. 2017 Mar;21(3):475-484. doi: 10.1007/s10995-016-2125-7.</citation>
    <PMID>27535131</PMID>
  </reference>
  <reference>
    <citation>Pessagno RA, Hunker D. Using short-term group psychotherapy as an evidence-based intervention for first-time mothers at risk for postpartum depression. Perspect Psychiatr Care. 2013 Jul;49(3):202-9. doi: 10.1111/j.1744-6163.2012.00350.x. Epub 2012 Aug 17.</citation>
    <PMID>23819670</PMID>
  </reference>
  <reference>
    <citation>O'Connor E, Senger CA, Henninger ML, Coppola E, Gaynes BN. Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 Feb 12;321(6):588-601. doi: 10.1001/jama.2018.20865.</citation>
    <PMID>30747970</PMID>
  </reference>
  <reference>
    <citation>Liu H, Yang Y. Effects of a psychological nursing intervention on prevention of anxiety and depression in the postpartum period: a randomized controlled trial. Ann Gen Psychiatry. 2021 Jan 4;20(1):2. doi: 10.1186/s12991-020-00320-4.</citation>
    <PMID>33397393</PMID>
  </reference>
  <reference>
    <citation>Avalos LA, Raine-Bennett T, Chen H, Adams AS, Flanagan T. Improved Perinatal Depression Screening, Treatment, and Outcomes With a Universal Obstetric Program. Obstet Gynecol. 2016 May;127(5):917-925. doi: 10.1097/AOG.0000000000001403.</citation>
    <PMID>27054938</PMID>
  </reference>
  <reference>
    <citation>Byatt N, Simas TA, Lundquist RS, Johnson JV, Ziedonis DM. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynaecol. 2012 Dec;33(4):143-61. doi: 10.3109/0167482X.2012.728649. Review.</citation>
    <PMID>23194018</PMID>
  </reference>
  <reference>
    <citation>Sockol LE. A systematic review and meta-analysis of interpersonal psychotherapy for perinatal women. J Affect Disord. 2018 May;232:316-328. doi: 10.1016/j.jad.2018.01.018. Epub 2018 Feb 1. Review.</citation>
    <PMID>29501991</PMID>
  </reference>
  <reference>
    <citation>Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord. 2015 May 15;177:7-21. doi: 10.1016/j.jad.2015.01.052. Epub 2015 Feb 2. Review.</citation>
    <PMID>25743368</PMID>
  </reference>
  <reference>
    <citation>Haga SM, Drozd F, Lisøy C, Wentzel-Larsen T, Slinning K. Mamma Mia - A randomized controlled trial of an internet-based intervention for perinatal depression. Psychol Med. 2019 Aug;49(11):1850-1858. doi: 10.1017/S0033291718002544. Epub 2018 Sep 7.</citation>
    <PMID>30191779</PMID>
  </reference>
  <reference>
    <citation>Shorey S, Ng YPM, Ng ED, Siew AL, Mörelius E, Yoong J, Gandhi M. Effectiveness of a Technology-Based Supportive Educational Parenting Program on Parental Outcomes (Part 1): Randomized Controlled Trial. J Med Internet Res. 2019 Feb 13;21(2):e10816. doi: 10.2196/10816.</citation>
    <PMID>30758289</PMID>
  </reference>
  <reference>
    <citation>Goodman JH. Women's attitudes, preferences, and perceived barriers to treatment for perinatal depression. Birth. 2009 Mar;36(1):60-9. doi: 10.1111/j.1523-536X.2008.00296.x.</citation>
    <PMID>19278385</PMID>
  </reference>
  <reference>
    <citation>Smith-Nielsen J, Matthey S, Lange T, Væver MS. Validation of the Edinburgh Postnatal Depression Scale against both DSM-5 and ICD-10 diagnostic criteria for depression. BMC Psychiatry. 2018 Dec 20;18(1):393. doi: 10.1186/s12888-018-1965-7.</citation>
    <PMID>30572867</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>May 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2021</study_first_posted>
  <last_update_submitted>June 5, 2021</last_update_submitted>
  <last_update_submitted_qc>June 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Shay Erisson</investigator_full_name>
    <investigator_title>Physician, Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mood Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

